Edgewise Therapeutics Inc EWTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
18.18UNCH (UNCH)
Volume
17,585
Close
18.18quote price arrow up+0.50 (+2.83%)
Volume
481,431
52 week range
5.12 - 21.60
Loading...
  • Open17.66
  • Day High18.20
  • Day Low17.46
  • Prev Close17.68
  • 52 Week High21.60
  • 52 Week High Date05/08/24
  • 52 Week Low5.12
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap1.698B
  • Shares Out93.41M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta0.22
  • YTD % Change66.18

KEY STATS

  • Open17.66
  • Day High18.20
  • Day Low17.46
  • Prev Close17.68
  • 52 Week High21.60
  • 52 Week High Date05/08/24
  • 52 Week Low5.12
  • 52 Week Low Date11/10/23
  • Market Cap1.698B
  • Shares Out93.41M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta0.22
  • YTD % Change66.18

RATIOS/PROFITABILITY

  • EPS (TTM)-1.53
  • P/E (TTM)-11.84
  • Fwd P/E (NTM)-11.99
  • EBITDA (TTM)-121.577M
  • ROE (TTM)-24.51%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Edgewise Therapeutics Inc

 

Profile

MORE
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing novel therapeutics for muscular dystrophies and serious cardiac conditions. It has built its muscle-focused drug discovery platform. Its platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially...
Peter Thompson M.D.
Independent Chairman of the Board, Co-Founder
Kevin Koch Ph.D.
President, Chief Executive Officer, Director
R. Michael Carruthers
Chief Financial Officer
John Moore
General Counsel
Address
1715 38Th St
Boulder, CO
80301
United States

Top Peers

SYMBOLLASTCHG%CHG
SANA
Sana Biotechnology Inc
8.55-0.72-7.77%
INBX
Inhibrx Inc
34.49+0.12+0.35%
FUSN
Fusion Pharmaceuticals Inc
21.46-0.08-0.37%
KURA
Kura Oncology Inc
22.98+1.11+5.08%
SNDX
Syndax Pharmaceuticals Inc
20.92-1.02-4.65%